MoneyWorks4Me

The sales for the December 2023 quarter moved down to Rs. 128.97 millions as compared to Rs. 140.39 millions during the year-ago period.The Net Loss for the quarter ended December 2023 is Rs. -1.27 millions as compared to Net Loss of Rs. -2.27 millions of corresponding quarter ended December 2022Operating profit for the quarter ended December 2023 rose to 12.86 millions as compared to 12.48 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 128.97 140.39 -8.13 410.93 505.20 -18.66 661.71 694.30 -4.69
Other Income 0.25 0.90 -72.22 2.24 2.01 11.44 5.11 5.92 -13.68
PBIDT 12.86 12.48 3.04 54.48 72.25 -24.60 92.87 90.07 3.11
Interest 5.66 5.65 0.18 16.94 18.56 -8.73 23.82 20.66 15.30
PBDT 7.20 6.83 5.42 37.54 53.69 -30.08 69.05 69.41 -0.52
Depreciation 8.90 9.85 -9.64 26.74 29.21 -8.46 39.17 35.48 10.40
PBT -1.70 -3.02 -43.71 10.80 24.48 -55.88 29.88 33.93 -11.94
TAX -0.43 -0.75 -42.67 2.70 6.12 -55.88 7.47 7.50 -0.40
Deferred Tax 0.50 0.52 -3.85 1.38 1.40 -1.43 1.97 3.05 -35.41
PAT -1.27 -2.27 -44.05 8.10 18.36 -55.88 22.41 26.43 -15.21
Equity 54.85 54.85 0.00 54.85 54.85 0.00 54.85 54.85 0.00
PBIDTM(%) 9.97 8.89 12.17 13.26 14.30 -7.30 14.03 12.97 8.19
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..